Background Although new HPV vaccines have been developed and are in the process of
implementation, anogenital warts remain a very frequent problem in clinical practice …

Genital human papillomavirus (HPV) infection is the most common sexually transmitted
disease. Each year 1 million new cases of genital warts are diagnosed, two thirds of which …

This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …

External genital warts (EGWs) are visible warts that occur in the perigenital and perianal
regions. They are due primarily to non-oncogenic human papillomavirus (HPV) types …

Background Anogenital warts (AGW) can cause economic burden on healthcare systems
and are associated with emotional, psychological and physical issues. Objective To provide …

Genital warts (condyloma acuminata) have been documented since the time of Hippocrates,
and cutaneous warts were reported by the first century AD. It was not until the late eighteenth …

Imiquimod : Current Opinion in Infectious Diseases Imiquimod : Current Opinion in Infectious
Diseases Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …

Topical imiquimod 5% cream (Aldara™) is an immune response modulator that is indicated
for the treatment of external anogenital warts, superficial basal cell carcinoma and actinic …

Objective Clinical efficacy and safety of Polyphenon® E, a defined green tea extract, in
external genital warts. Design Randomized, double‐blind, placebo‐controlled study for up to …

BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …